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Summary To assess the levels of psychological distress and identify predictors of anxiety/depression caseness after cancer cure, a national
population of 557 Hodgkin's disease (HD) survivors was surveyed. The respondents [204 women, 255 men, mean age 44 years (SD = 12)]
returned a mailed questionnaire including The Hospital Anxiety and Depression Scale (HADS). Disease and treatment variables were based
on the hospital records. A total of 27% had caseness scores (anxiety, 14.5%; depression, 4%; anxiety and depression, 8.5%). In a multiple
logistic regression analysis, anxiety caseness was predicted by low educational status [OR (odds ratio) = 2.07, 95% Cl = 1.02-4.22],
observational period 7 years or longer (7-10 years: OR = 3.07, 95% Cl = 1.26-7.47), combined irradiation and chemotherapy treatment
(OR = 2.77, 95% Cl = 1.17-6.54) and psychiatric symptoms before HD (OR = 2.55, 95% Cl = 1.40-4.65) or during treatment (OR = 3.51,
95% Cl = 2.08-5.90). Depression caseness was predicted by age (OR = 1.03, 95% Cl = 1.00-1.06) and psychiatric symptoms before HD
(OR = 5.1, 95% Cl = 2.55-10.31) Anxiety cases are more prevalent than in the general Norwegian population, and were found to be most
common 7-10 years after treatment. The most intensive treatment was associated with increased risk for anxiety caseness. The subjects
experienced distress during treatment precedes difficulties in long-term adjustment. Focusing on these predictors during treatment and
follow-up controls may improve long-term outcome.
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Most of the survivors of Hodgkin's disease (HD) are in early
adulthood, and the price of survival in terms of physical, social
and psychological disturbances is therefore highly relevant. Such
long-term effects may influence the choice of treatment and
follow-up/rehabilitation programmes.
Psychological sequelae in cancer survivors differ from psycho-
logical problems during initial diagnosis and treatment (Tross and
Holland, 1990). Psychological sequelae may result from the
anticipatory threat of death, arising from personal confrontation
with mortality (Tross and Holland, 1990). The survivor may expe-
rience fears of recurrence and a sense of tenuous longevity,
producing anxiety, depressive moods and ideas and a damaged
body image (the Damocles syndrome; Koocher and O'Malley,
1981). Psychological sequelae may also be a residual response to
diagnosis and treatment, such as a stress syndrome following cata-
strophic experiences (Tross and Holland, 1990).
During the first year afterdiagnosis, as many as 63% ofpatients
with HD or non-Hodgkin lymphomas may present psychological
distress (anxiety or depression) compatible with caseness or
borderline caseness (Devlen et al, 1987). However, these symp-
toms are often of short duration, and psychiatric morbidity has
been found greatest before treatment (Devlen et al, 1987). Fobair
et al (1986) found increased rates of depression during the first 3
years after termination oftreatment, but psychological distress has
been considered to have a variable relationship to time from diag-
nosis (Cella and Tross, 1986). Late-stage disease (Cella and Tross,
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1986) and greater treatment toxicity (Devlen et al, 1987) have
been found to predict problems in post-treatment adaption.
However, little is known about possible predictors of psycho-
logical distress among survivors of HD in the medical, socio-
demographic and psychosocial domain (Komblith et al, 1992).
Psychological sequelae reported among HD survivors include:
illness-related concems; lowered motivation for intimacy; coping
strategies towards illness being more avoidable (Cella and Tross,
1986); and conditioned nausea in response to reminders of
chemotherapy (Devlen et al, 1987; Komblith et al, 1992). The
clinical significance of these late effects is unclear. In fact, many
survivors experience positive consequences, such as increased
appreciation of life, enhanced self-esteem and sense of personal
direction, and closer family ties (Yellen et al, 1993). In clinical
practice, late effects such as anxiety and depression are of special
relevance as therapeutic interventions are available.
Before 1985, 85% ofallNorwegian adultHDpatients weretreated
attheNorwegian RadiumHospital (NRH) (Abrahamsenet al, 1993).
Since 1985, NRH has treated patients from a defined region consti-
tuting half of Norway's population. Thus, a national population of
HD survivors is available for a long-term follow-up study. This
cross-sectional study was conducted to determine the level of
psychological distress among survivors ofHD andhow this isrelated
to sociodemographic variables and disease treatment characteristics
as well as the predictors ofanxiety and depression caseness.
MATERIAL AND METHODS
Subjects and data collection
Patients admitted to the NRH between 1971 and 1991 with HD
and known to be alive by the end of 1993 were approached by
post. Only patients who had received treatment and were between
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15 and 61 years at the time of diagnosis and 74 years or younger
by the end of 1993 were included in this study. Non-compliers
received one reminder.
Measures
Using the Tumor Registry of NRH (Abrahamsen et al, 1993),
information on date of diagnosis, stage, histology, treatment and
follow-up, including current disease status, ofall patients admitted
to NRH for HD was available. The Norwegian version of The
Hospital and Depression Scale (HADS) (Zigmond and Snaith,
1983) was included in a self-report questionnaire. The HADS
consists of 14 items, measuring depression (seven items) and
anxiety (seven items). Each item is scored on a four-point scale
(0-3). Sum scores for either subscale (anxiety or depression
respectively) are calculated by simple addition.
HADS has been used in studies of distress among cancer
patients in general (Moorey et al, 1991; Carroll et al, 1993;
Table 1 Subject characteristics (n = 459)
Age at time of study* (yrs)
<29
30-39
40-49
50-59
.60
Gender
Female
Male
Educational status
< 10yrs
11-12 yrs
> 13 yrs
University
Marital status
Single
Married/cohabitant
Divorced/separated
Widow/widower
Stage/substagea
IV
Substage A
Substage B
Primary treatment
Irradiation
Chemotherapy
Irradiation + chemotherapy
Observational period" (yrs)
3-6
7-10
11-14
15-23
Current disease status
No relapse
Relapse, currently no disease
Relapse with current diseaseb
50 (11)
117 (26)
169 (37)
67 (15)
56 (12)
Ibbotson et al, 1994) and among HD patients (Razavi et al, 1990).
The psychometric properties are well documented (Razavi et al,
1990; Ibbotson et al, 1994) and the instrument performs well in
cancer patients free of disease (Ibbotson et al, 1994). The
constructors of HADS recommended two possible cut-offs (8 or
higher or 11 orhigher on either scale) for case definition (Zigmond
and Snaith, 1983). In this study, caseness refers to the lower cut-
offif not stated otherwise.
The questionnaire also included items on sociodemographic
status at the time ofdiagnosis and at the present time. Six questions
addressed psychiatric symptoms (ifexperienced and type ofdomi-
nating symptom), psychiatric treatment (psychiatrist/psychologist,
medication, hospital/clinic) and consulting a physician for psychi-
atric complaints. These questions were asked in relation to the time
before, during and after treatment.
Analysis
The data were analysed using the SPSS for Windows v. 6.1 soft-
ware (SPSS, IL, USA). Statistical procedures included chi-square
statistics, two-sided t-tests (independent samples), one-way
ANOVAs, Pearson correlations, reliability estimation and multiple
logistic regression. The level of significance was set at P < 0.05.
Multiple comparisons (one-way ANOVAs) were performed by the
use of Scheffe's test.
RESULTS
A total of 557 former patients were eligible, and 459 replied
204 (44) (compliance rate = 82.4%). The characteristics of the respondents
255 (56) are given in Table 1. Mean age at time of diagnosis was 32 years
(s.d. = 11.8).
168 (37) There were no statistically significant differences between
103 (23) compliers and non-compliers in relation to age, disease stage, type
70 (15) of treatment or time since diagnosis. More women (86%) than men
117 (25) (80%) returned the questionnaire (chi-square 3.83, P 0.050).
Complete sets of either HADS anxiety or HADS depression
343 (75) scores were available for 439 (96%) and 447 (97%) subjects
35 (8) respectively. Mean anxiety score was 5.0 (s.d. = 4.1, range =
13 (3) 0-19). On the depression subscale, mean score was 3.1 (s.d. = 3.3,
range = 0-16). The anxiety and depression subscales were
119 (26) strongly correlated (r = 0.62, P < 0.001). Reliability estimated by
159 (35) Cronbach's alpha was 0.82 and 0.86 for depression items and
108 (24) anxiety items respectively.
73 (16)
312 (68)
147 (32)
176 (38)
79 (17)
204 (44)
89 (19)
101 (22)
108 (24)
161 (35)
425 (93)
29 (6)
5 (1)
Table 2 Anxiety and depression mean scores and cases by gender
Males Females t-value/PLvaluea
(n = 243) (n = 196)
Anxiety (mean) 4.6 5.5 -2.2/0.028
Depression (mean) 3.3 3.0 0.95/0.34
Chi-square/P-valueb
Anxiety cases 19.8 27.6 3.7/0.054
(% n)
Depression cases 13.7 11.6 0.41/0.52
(% n)
aStudent's t-tests for difference male/female mean scores with corresponding
P-values; bchi-square for difference in male/female proportions with
corresponding P-values.
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aAccording to the Ann Arbor staging classification; brelapse in 1993 or 1994.
*Mean = 44, s.d. = 11.8; **mean = 12, s.d. = 5.5.
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Table 3 Distress in relation to educational status
Educational status
< 10 years 11-12 years > 13 years University
(n = 157) (n = 99) (n = 70) (n = 112)
Anxiety (mean) 5.53a 4.71 5.66 4.01a
Anxiety cases 27b 21b 29b 16b
(% n)
Depression (mean) 3.88c 2.71c 3.53 2.25c
Depression cases 19d 8d 16d 7d
(% n)
aF= 3.61, P < 0.05, by one-way ANOVA for difference in means; bChi-
square = 6.07, P > 0.05, for difference in proportions; cF= 6.85, P < 0.05, by
one-way ANOVA for difference in means; dChi-square = 11.04, P= 0.01, for
difference in proportions.
Table 4 Distress in relation to self-reported psychiatric symptoms before
HD and during treatment
Psychiatric symptoms Psychiatric symptoms
before HD during treatment
Yes (n = 80) No (n = 372) Yes (n = 157) No (n = 294)
Anxiety (mean) 7.6a 4.5a 7.Oa 3.8a
Anxiety cases 42b 19b 38b 14b
(% n)
Depression (mean) 4.9a 2.8a 40a 2.6a
Depression cases 31b 9b 19c 9c
(% n)
ap < 0.001 by t-tests for difference in means; bp < 0.001 by chi-square for
difference in proportions; cp= 0.004 by chi-square for difference in
proportions.
A total of 27% of the subjects had scores on the anxiety or the
depression subscales equal to or above a caseness score of 8. A
total of 4% had caseness scores on the depression subscale only
and 14.5% on the anxiety subscale only, whereas 8.5% scored
above 8 on both scales. If the threshold for caseness was set at 11
or higher, a total of 13% were cases. Thus, 9% were anxiety cases,
2% depression cases and 2% cases on both scales.
Distress in relation to sociodemographic variables
The level of anxiety was higher among women than among men.
Anxiety cases tended to be more frequent among women (28%)
than among men (20%) (P = 0.054) (Table 2).
The depression score increased with increasing age, and was
higher among those aged 50-59 years (mean = 3.9, s.d. = 3.4) and 60
years or older (mean = 4.1, s.d. = 3.3) than in those under 29 years
(mean = 1.8, s.d. = 1.9) (F=4.5, P<0.05). There was alinearassoci-
ation between increasing numbers ofdepression cases and increasing
age (chi-square = 7.9, P < 0.001), and the highest proportion of
depression cases was found in the age group 50-59 years (22%).
Both the anxiety and depression scores were highest among
those separated or divorced [anxiety mean = 5.9 (s.d. = 4.1),
anxiety cases = 31%, depression mean =4.2 (s.d. = 3.5), depression
cases = 18%]. Their depression score was significantly higher than
among the unmarried (mean = 2.1, s.d. = 2.7; F = 3.68, P < 0.05).
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Figure 1 Per cent anxiety (U) and depression (LI) cases among subjects
grouped by years since diagnosis
Subjects who had attended university had the lowest levels of
both anxiety (mean = 4.1, s.d. = 3.5) and depression (mean = 2.3,
s.d. = 2.8) (Table 3).
The anxiety scores differed significantly between subjects who
had attended university and the poorly educated (anxiety mean =
5.5, s.d. = 4.5). The subjects educated at universities and subjects
educated for 11-12 years (depression mean = 2.7, s.d. = 2.7) had
lower depression scores than subjects with the least education
(depression mean = 3.9, s.d. = 3.6).
The frequency ofdepression cases was lowest among those who
had attended university (7%) and highest among subjects with the
poorest education (19%) (chi-square = 11.04, P = 0.01).
There were no significant differences in levels of distress or in
frequency ofcases in relation to habitual status at the time ofdiag-
nosis (living alone, living with their parents or cohabiting).
Distress in relation to disease and treatment
characteristics
The levels of distress or frequency of cases (both depression and
anxiety) did not differ significantly in relation to stage, type of
treatment (irradiation, chemotherapy or both) or number of
chemotherapy treatments. However, there was a close to signifi-
cant difference in the proportion of depression cases in relation to
stage (stage 1, 15%; stage II, 10%; stage III, 9%; stage IV, 21%;
chi-square = 7.67, P = 0.053). No significant differences in levels
of distress or frequency of cases were found in relation to type of
irradiation (mantle vs other types), type of chemotherapy or
having undergone spleenectomy or not.
Subjects with substage B had higher depressive scores (mean =
3.8, s.d. = 3.5) and more frequent depression cases (18%) than
subjects with substage A (depression mean = 2.8, s.d. = 3.2; depres-
sion cases = 10%) (t=-2.66, P=0.008; chi-square = 5.37, P = 0.02).
Subjects observed 3-6 years after the diagnosis had the lowest
depression score (mean = 2.3, s.d. = 2.4), and this was lower
than in subjects observed at 7-10 years (mean = 3.8, s.d. = 3.8)
(F = 3.49, P < 0.05) (Figure 1).
The number of both anxiety and depression cases was nearly
three times higher among subjects observed 7-10 years after diag-
nosis than among subjects observed 3-6 years afterdiagnosis. This
reached statistical significance only for the anxiety cases (chi-
square = 8.26, P = 0.04).
Relapse was not associated with any differences in levels of
distress (depression mean = 2.5, s.d. = 2.7; anxiety mean = 4.3,
s.d. = 3.3) or in the proportion ofcases compared with subjects who
had not relapsed. Of the 70 subjects (52 men, 18 women) who
reportedhavingtriedbuthaving failedtoconceivechildren, nosignif-
icant differences in either levels of distress or in the proportion of
cases were found compared with those who had conceived children.
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Table 5 Multiple logistic regression for prediction of anxiety cases (n = 425)
Predictor variables Number of cases (at risk) ORa 95% Clb
Sex
Male
Female
Age (continuous)
Martal status
Unmarried
Married/cohabitant
Widow/widower
Separated/divorced
Educational status
University
> 13 yrs
11-12 yrs
< 10 yrs
Observational period
3-6 yrs
7-10 yrs
11-14 yrs
15-23 yrs
Stage
Stage I
Stage II
Stage IlIl
Stage IV
Substage
A
B
Primary treatment
Chemotherapy
Chemotherapy and irradiation
Irradiation
PSP
No
Yes
PSDT
No
Yes
47 (238)
49 (187)
13 (61)
72 (251)
2 (10)
9 (31)
17 (111)
19 (68)
20 (96)
40 (150)
10 (82)
29 (94)
24 (97)
33 (152)
24 (105)
34 (151)
25 (101)
13 (68)
61 (288)
35 (137)
11 (73)
51 (195)
34 (157)
64 (349)
32 (76)
37 (272)
59 (153)
1.18
0.99
0.80
0.73
1.02
1.88
1.63
2.07a
3.07a
2.86a
2.61a
0.82
1.36
1.00
1.03
2.77a
2.71
2.55a
3.51a
0.70-1.98
0.96-1.02
0.45-2.14
0.11-4.94
0.33-3.16
0.82-4.28
0.75-3.55
1.02-4.22
1.26-7.47
1.14-7.22
1.01-6.72
0.41-1.67
0.59-3.17
0.36-2.79
0.55-1.92
1.17-6.54
0.96-7.66
1.40-4.65
2.08-5.90
aOR = odds ratio adjusted for all other variables in the table; b95% Cl = 95% confidence intervals for odds ratio; c significant at
5% level; PSP, psychiatric symptoms before HD; PSDT, psychiatric symptoms during treatment.
Distress and psychiatric symptoms before HD and
during treatment
Eighty subjects (18%) stated they had experienced psychiatric
symptoms before HD. Of these, 42 (53%) had been anxious, 43
(54%) had felt depressed and 18 (23%) had sleeping problems.
Three had been psychotic and six had abused alcohol or drugs.
A total of 157 subjects (35%) reported psychiatric symptoms
during treatment. Forty-four of these also reported psychiatric
symptoms before HD. Among the former, seventy-four (48%) had
been anxious, 51 (32%) had felt depressed and 47 (30%) had
sleeping problems. Two had abused alcohol or drugs. Twenty-two
(14%) had consulted apsychiatrist or apsychologist, and 84 (56%)
had received psychotropic medication [anxiolytics, 58 (34%);
hypnotics, 44 (28%)] (Table 4).
Among subjects reporting psychiatric symptoms before HD or
during treatment there were higher levels of distress and more
cases compared with subjects reporting no such symptoms.
Predictors of anxiety and depression cases
Multiple logistic regression analyses were performed to identify
predictors of either anxiety or depression caseness. Number and
type of chemotherapy/irradiation, having relapsed or having been
spleenectomized were not included as these variables were not
significant predictors in the univariate analysis (Table 5).
As for anxiety cases, both the time from diagnosis (observa-
tional period 7 years or longer) and type of treatment (irradiation
and chemotherapy combined) were significant predictors of case-
ness. Irradiation treatment solely was close to significance (odds
British Journal ofCancer (1997) 76(6), 791-796 0 CancerResearch Campaign 1997Anxietyanddepression among Hodgkin survivors 795
ratio = 2.7, 95% CI = 0.96-7.66). Low educational status, psychi-
atric symptoms before HD or during treatment also predicted
anxiety caseness.
None of the disease or treatment variables tested in the same
model predicted depression caseness. Such cases were only
predicted by age (odds ratio = 1.03, 95% CI = 1.00-1.06) and
psychiatric symptoms before HD (odds ratio = 5.1, 95% CI =
2.55-10.31). Similar results were repeated when anxiety and
depression caseness were defined by the upper end ofthe border-
line range (i.e. case = 11/12).
DISCUSSION
The majority of psychosocial studies of cancer survivors have
been conducted in the United States. Cultural differences and
differences in treatment regimens may influence late effects, and
therefore the results ofthe US studies cannot be generalized to the
European setting (Van Tulder et al, 1994).
In the present study, the sample size, the high compliance rate,
the long observational period and the standardized treatment regi-
mens applied yield opportunities for assessing the disease and
treatment variables' effects upon the psychological outcome. The
study design restricted collection of data of physical late effects
such as cardiopulmonary sequelae (Lund et al, 1996), which solely
or in interaction with the cancerexperience may affectthe levels of
distress (Cella and Tross, 1986; Tross and Holland, 1990). In long-
term prospective studies, on the other hand, large numbers of
patients are lost to follow-up.
By choosing the lower recommended threshold for case defini-
tion (Zigmond and Snaith, 1983), the proportion offalse-negative
cases is reduced at the possible expense of more false-positive
cases. In other studies, the HADS has been employed with case-
ness scores ranging from 13 on both scales combined (Razavi etal,
1990), through 8 on either scale (Carroll et al, 1993) to 11 on either
scale (Hopwood et al, 1991). This partly reflects the different
criteria employed in validation studies ofHADS, such as including
adjustment disorders (Razavi et al, 1990) or omitting them
(Ibbotson et al, 1994). It is therefore important to stress that
HADS, like other screening instruments, gives prevalence esti-
mates ofmorbidity rather than accurate measures ofdisorders.
Other studies of cancer survivors have found prevalences of
distress cases at the same level as in the present study. As other
studies have used other instruments, such comparisons are tentative.
In a US study of survivors from advanced HD, the number of
distress cases measured by the Brief Symptom Inventory was 22%
(Komblith et al, 1992). In another Norwegian follow-up study of
cured cancer patients (head and neck cancer), 31% scored above the
cut-offfor caseness (measured by the General Health Questionnaire,
20-item version) (Bjordal and Kaasa, 1995). Irrespective of HADS
caseness being defined by the lower threshold (e.g. 8 or higher) or
the higher (e.g. 11 or higher), the prevalence of cases (mainly
anxiety) in the present study is higher than in the general Norwegian
population, in which the prevalence ofanxiety and depression cases
(measured by the Hopkins Symptoms Check List) was estimated to
be 3.3% and 3.0% respectively (Moum et al, 1991). In the general
population, the frequency of depression cases also increases with
increasing age (Moum et al, 1991).
Compared with the general Norwegian population, anxiety
cases are found relatively more frequently than depression cases.
This is similar to that found among cancer patients in remission
(Carroll et al, 1993) and differs from the high prevalence of
depression among cancer patients with active or advanced disease
(Carroll et al, 1993; McDaniel et al, 1995). Among these, the high
prevalence of depression may be linked to losses, either actual
such as loss of function or anticipated such as death. The high
prevalence of anxiety cases after cure may therefore support the
concept ofa persisting stressor (Cella and Tross, 1986). Clinically,
anxiety symptoms should consequently be focused in controls of
cured HD patients.
Predictors of cases
The increased number of cases 7-10 years after cure supports the
concept of a non-linear relationship between distress and time
since diagnosis. This may be linked to alessening ofpsychological
defence with time (Cella and Tross, 1986; Yellen et al, 1993). The
follow-up controls atNRH, after termination ofthe treatment, may
also have served as a 'buffer' against psychological distress. At
NRH these controls have been terminated 5-10 years after cure. At
termination of treatment, a 'paradoxical' rise in anxiety, specifi-
cally related to separation from staff, has been observed (Massie,
1990). Our findings may indicate a similar effect in relation to
termination of controls and thereby an important psychological
aspect of these controls. At termination ofcontrols, psychological
reactions to termination should therefore be addressed.
The findings of the insignificant effects of both stage and
substage in relation to caseness are areminder to medical staffthat
the cancer experience itself is subjective. Chemotherapeutic toxi-
city predicts post-treatment distress, possibly mediated through the
side-effects ofthe more toxic regimens (Devlen et al, 1987). In the
present study, those treated with the combined regimen were
mostly patients with substage B and/or stage II or III. They
received chemotherapy to reduce tumour masses before full irradi-
ation regimen and thus the most extensive treatment. This supports
previous findings of the treatment's impact on later psychological
adjustment (Cella and Tross, 1986).
Formal educational level has been proposed as the best measure
for overall socioeconomic status among cured HD patients,
because the adaptional needs such as problem solving and long-
term planning is affected by the educational level (Komblith et al,
1992). Low socioeconomic status is considered to cause increased
levels of distress in the general population (Wheaton, 1980). One
may question whether low formal education in itself increases the
risk for distress or if this finding merely reflects the general rela-
tion between social status and distress.
Time since exposure, social desirability and mode of adminis-
tration affect recall (S0rensen et al, 1994). The use of
psychotropics is under-reported in surveys (S0rensen et al, 1994).
Recall bias may therefore affect the estimates ofpsychiatric prob-
lems both before and during the treatment and thus their observed
predictive values on caseness. However, the number reporting
psychiatric symptoms during the treatment is consistent with other
prevalence estimates of psychiatric problems among lymphoma
patients (Devlen et al, 1987; Razavi et al, 1992). This supports the
validity of our estimates.
Detecting psychiatric problems before and during treatment is
part ofthe clinician's duties, but such problems often remain unde-
tected (Maguire, 1985; Cull et al, 1995). A past psychiatric history
increases the risk for distress among cancer patients (Harrison and
Maguire, 1994). The increased risk for anxiety caseness after
cure associated with psychiatric complaints during treatment is
clinically highly relevant. However, the possible recall bias and
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cross-sectional design of the study imply some caution regarding
this finding. Nearly 50% had not received treatment
(psychotropics or psychiatric counselling) during the treatment
phase, but other interventions may have been applied that were
undetected by our data collection. Thus, this points to possible
improvements in care that might reduce the level ofanxiety among
the survivors.
CONCLUSION
This study shows a rather high frequency of anxiety cases among
survivors ofHD. Both the increased risk associated with combined
treatment and the non-linear relationship between distress and
time from diagnosis are highly relevant in the follow-up
programmes. The effect ofdistress during treatment upon psycho-
logical outcome, underlines the importance of focusing psycho-
logical disturbances in cancer care. Thus, the majority of cured
HD patients survive without distress at caseness level.
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